NCATS Small Businesses: The Diversity Supplement is BACK! 🎉 Calling all NCATS SBIR/STTR awardees! We're excited to announce that the opportunity to apply for administrative supplements to enhance diversity in your research teams has been reissued! Here's how the Diversity Supplement can make a difference: ➡️ Recruit & mentor students, postdocs, and eligible investigators from underrepresented groups ➡️ Support the inclusion of researchers with disabilities by providing funds to accommodate their needs and ensure continued participation in vital research projects ➡️ Build a more inclusive & innovative research environment Learn more about this funding opportunity (PA-23-255) & eligibility requirements here: Small Business Resources: https://go.nih.gov/OujjbuE Don't miss out! Applications are accepted on a rolling basis. Share this post and help us champion diversity in translational research!
National Center for Advancing Translational Sciences (NCATS)
Research
Rockville, Maryland 18,607 followers
About us
The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health, conducts and supports research on the science and operation of translation to allow more treatments to get to more patients more quickly. The center focuses on what is common across diseases and the translational process by studying translation on a system-wide level as a scientific and operational problem. Working in partnership with the public and private sectors, NCATS strives to develop innovations to reduce, remove or bypass costly and time-consuming bottlenecks in the translational research pipeline; demonstrate their usefulness; and disseminate the resulting data to the broader scientific community. For more information, visit https://ncats.nih.gov. engagement ≠ endorsement
- Website
-
https://ncats.nih.gov
External link for National Center for Advancing Translational Sciences (NCATS)
- Industry
- Research
- Company size
- 201-500 employees
- Headquarters
- Rockville, Maryland
- Type
- Government Agency
- Founded
- 2011
Locations
-
Primary
9609 Medical Center Dr
Rockville, Maryland 20850, US
Employees at National Center for Advancing Translational Sciences (NCATS)
-
Thomas C. Radman
Program Director at National Center for Advancing Translational Sciences
-
Rafat Sarosh
AI for Enterprise, Relentless Optimists and Practical Builder.
-
Audie Atienza
Senior Program Officer, NCATS/NIH [VIEWS ARE MY OWN]; Founder, The XA Project [501(c)(3) non-profit]
-
Dmitry Krantsberg
Updates
-
NCATS, the National Human Genome Research Institute (NHGRI), Simon Fraser University and Roche created a screening approach that can sift thousands of drug compounds in a predictive, disease-relevant and cell-based system. This design rapidly revealed drugs that can rescue and help restore defective versions of an enzyme that is a contributor to Gaucher disease — a #RareDisease — and #ParkinsonsDisease. Learn how this innovative approach is speeding up new therapies for these diseases: https://go.nih.gov/gG5QYdS
-
NCATS Office of Translational Medicine Director Josh Fessel, M.D., Ph.D., spoke at the Chronic Disease Day hosted by Good Days on Capitol Hill. Dr. Fessel noted some chronic diseases are common; many others are rare — highlighting the need to support the treatment and prevention of #RareDiseases as well as common diseases. Read more on Dr. Fessel: https://go.nih.gov/UAH0WVI Read more on Chronic Disease Day: https://lnkd.in/ewYicN5j
In July, NIAMS Director Lindsey Criswell spoke at a congressional briefing on chronic disease management and prevention. Taking place in the Rayburn House Office Building, the event also featured speakers from NIH’s National Center for Advancing Translational Sciences (NCATS), the CDC’s National Center for Chronic Disease Prevention and Health Promotion, and more. The NIH Record has the full story: https://lnkd.in/ewYicN5j
-
In one week, our Assay Guidance Manual Program is hosting a free 𝐼𝑛 𝑠𝑖𝑙𝑖𝑐𝑜 Drug Discovery Virtual Workshop. This event will cover concepts and best practices for integrating #ArtificialIntelligence and #MachineLearning into #DrugDiscovery pipelines. If you didn't get a chance to register, tune into the two-day event using the links below. Day 1 — Wednesday, Oct. 23, 2024, 11:00 a.m.–5:15 p.m.: https://lnkd.in/ekb65Bds Day 2 — Thursday, Oct. 24, 2024, 11:00 a.m.–5:15 p.m.: https://lnkd.in/ePn-APeG View the agenda featuring newly-minted Nobel laureate David Baker, Ph.D.: https://lnkd.in/ecrUW9eB
-
🚨 Last Chance for Game-Changing Research Funding! 🚨 The clock is ticking! ⏳ Don't miss your chance to secure NIH SBIR/STTR funding for your groundbreaking research. The deadline to apply is Oct. 18. This is your opportunity to: • Revolutionize batch evaporation with your innovative benchtop device. • Advance personalized medicine by developing liver and brain organoids from iPS cells. Don't wait! Submit your application today: https://lnkd.in/ezcaVEpj #NCATSsbir #SBIRSTTR #researchfunding #innovation #biotech
-
If you’re attending SACNAS #2024NDiSTEM, hear NCATS Intramural Translational Training Director Dr. Belen Hurle speak! ➡️Nov. 1 at 5:15 p.m. EDT for Training at the NIH: Success Stories and Advice from Hispanic Leaders ➡️Nov. 2 at 1:30 p.m. EDT for Found in Translation: Diversity and Inclusion in Translational Research Learn more about Dr. Hurle: https://go.nih.gov/SjjJ5HM #TrueDiversity #HispanicHeritageMonth
-
Thank you to all participants! The answer is: True By advancing #TranslationalScience, we can make research more efficient and impactful, resulting in more treatments for all people more quickly. To learn more, explore the NCATS Strategic Plan for 2025–2030: https://go.nih.gov/8ksiTZ9
This content isn’t available here
Access this content and more in the LinkedIn app
-
Rare diseases research has a home at NCATS. We work with patients, advocates and researchers to get more treatments for all people more quickly, including people with #RareDiseases. We will continue leading research at National Institutes of Health because our research prioritizes discovering and developing rare disease therapies. Read about our impact today: https://go.nih.gov/njCpKfm
-
NCATS Division of #RareDiseases Research Innovation Deputy Director Dr. P.J. Brooks will speak at and moderate a panel during the National Organization for Rare Disorders Rare Diseases and Orphan Products Breakthrough Summit on Oct. 21. Learn more about Dr. Brooks: https://go.nih.gov/UxOVgNx #NORDSummit
-
⏰ The clock is ticking! NCATS Contract Solicitations are open for proposals until Oct. 18! NCATS is seeking innovations in: 🚀 Miniaturized Evaporation: Develop a compact, versatile benchtop device for efficient batch evaporation. 🧠 Scalable Organoids: Pioneer new methods for the scalable generation of liver and brain organoids from human iPS cells. Make an impact! Apply now: https://lnkd.in/ezcaVEpj #NCATSsbir
SAM.gov
sam.gov